REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 99 filers reported holding REPLIMUNE GROUP INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,568 | -25.0% | 16,807 | +1.7% | 0.00% | – |
| Q2 2023 | $383,548 | +30.2% | 16,518 | -1.0% | 0.00% | – |
| Q1 2023 | $294,622 | -26.9% | 16,683 | +12.5% | 0.00% | -100.0% |
| Q4 2022 | $403,213 | +57.5% | 14,824 | 0.0% | 0.00% | – |
| Q3 2022 | $256,010 | +26.7% | 14,824 | +28.3% | 0.00% | -100.0% |
| Q2 2022 | $202,000 | +3.1% | 11,554 | 0.0% | 0.00% | – |
| Q1 2022 | $196,000 | -37.4% | 11,554 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $313,000 | -4.6% | 11,554 | +4.4% | 0.00% | 0.0% |
| Q3 2021 | $328,000 | -18.6% | 11,071 | +5.6% | 0.00% | 0.0% |
| Q2 2021 | $403,000 | +21.8% | 10,484 | -3.3% | 0.00% | 0.0% |
| Q1 2021 | $331,000 | -13.1% | 10,846 | +8.6% | 0.00% | 0.0% |
| Q4 2020 | $381,000 | – | 9,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |